Prognosis of surgical excision combined with interventional therapy in treatment of hepatocellular carcinoma with microvascular invasion

LIU Jia-ye; LI Chuan; WEN Tian-fu; YAN Lyu-nan; YANG Jia-yin; LI Bo; WANG Wen-tao; XU Ming-qing; WU Hong

您当前的位置：

首页 >

文章列表页 >

Prognosis of surgical excision combined with interventional therapy in treatment of hepatocellular carcinoma with microvascular invasion

更新时间：2023-05-22

- Prognosis of surgical excision combined with interventional therapy in treatment of hepatocellular carcinoma with microvascular invasion
- null Issue 5, (2016)
- 作者机构：
  
  四川大学华西医院肝脏外科,四川,成都,610041
- 作者简介：
- 基金信息：
- DOI：
  CLC：
- Published：2016，
扫描看全文
LIU Jia-ye, LI Chuan, WEN Tian-fu, et al. Prognosis of surgical excision combined with interventional therapy in treatment of hepatocellular carcinoma with microvascular invasion. [J]. null (5).(2016)
DOI：

LIU Jia-ye, LI Chuan, WEN Tian-fu, et al. Prognosis of surgical excision combined with interventional therapy in treatment of hepatocellular carcinoma with microvascular invasion. [J]. null (5).(2016) DOI：

摘要

[摘要]目的分析手术切除后联合介入治疗肝细胞肝癌（HCC）伴微血管癌栓（MVI）患者的预后。方法选取我院2009年1月至2015年9月收治的296例手术切除后病理确诊为肝细胞肝癌伴微血管癌栓的连续病例作为研究对象，根据其术后是否联合应用介入治疗，分为单纯切除组（n=159）和切除术后联合介入组（n=137），分析2组患者的一般资料，对单因素分析后有显著性差异的指标进行Cox回归分析，并分别计算2组患者的长期生存率（OS）及无瘤生存率（DFS）。结果切除术后联合介入组在长期生存率及无肿瘤复发率方面均优于单纯切除组（OS:18% vs 8%

P=0.001；TRF:15% vs 8%

P=0.008）。多因素分析结果显示，慢性乙肝感染（HR 1.596

P=0.002

95%CI 1.194～2.131），肿瘤大于5 cm（HR 0.729

P=0.042

95%CI 0.539～0.989）以及多个肿瘤（HR 1.480

P=0.049

95%CI 1.002～2.186）是影响患者长期生存的不利因素。结论HCC伴MVI患者切除术后联合介入治疗可改善预后。

Abstract

Abstract: ObjectiveThe aim of this study is to analyze the long-time outcome of hepatocellular carcinoma（HCC） patients with microvascular invasion underwent liver resection combined with transarterial chemoembolization（TACE）.MethodsOur database of surgical resection from January 2009 to September 2015 was retrospectively analyzed.This study was conducted on 296 HCC patients with MVI.Patients were divided into two groups：one group underwent liver resection （n=159） and another for liver resection combined with TACE （n=137）.The 5-year overall survival rate (OS) and disease free survival (DFR) were compared.A multivariate Cox proportional hazards regression analysis was performed to assess the prognostic risk factors associated with overall survival rate.ResultsThe 5- year OS and 5- year DFR see significant difference （OS: 18%vs 8%

P=0.001；TRF:15%vs 8%

P=0.008）.Multivariate analysis revealed that HBsAg（HR 1.596

P=0.002

95% CI 1.194~2.131），tumor size>5 cm（HR 0.729

P=0.042

95% CI 0.539~0.989）as well as multiple tumors（HR 1.480

P=0.049

95% CI 1.002~2.186）were correlated to poor overall survival rate.ConclusionSurgical resection combined TACE for HCC patients with MVI realized a better prognosis than patients merely underwent therapy of resection.

关键词

肝细胞肝癌手术切除介入治疗预后总体生存率无瘤生存率

Keywords

hepatocellular carcinomaexcisoninterventional therapyprognosisoverall survivaldisease free survival

references

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Comparison of the prognosis of liver resection and transcatheter arterial chemoembolization for patients with Barcelona clinic liver stage C and portal vein tumor thrombus

Clinical significance of FEN1 regulating the occurrence and prognosis of hepatocellular carcinoma

Clinical efficacy of closure operation guided by transthoracic echocardiography with simply delivery sheath for patent foramen ovale

Curative effect and prognosis of Zheng's 4C suspension transumbilical laparoendoscopic single-site surgery for cervical cancer

Clinical study of intensity-modulated radiation therapy combined with camrelizumab in the treatment of advanced hepatocellular carcinoma

Related Author

WANG Yi

YANG Zhen-hua

BO Shang-zhu

XU Jun

QIU Hong-gen

ZHAO Jian-hong

CEN Hong-bing

YANG Zhi-yong

Related Institution

Gastroenterological Research Center of Sanxia University，First Clinic Institute of Sanxia University，People’s Hospital of Yichang City

Department of General Surgery,Yuanan People’s Hospital

Department of Hepatobiliary Surgery，Huanggang Central Hospital Affiliated to Changjiang University

Department of Pathology，Huanggang Central Hospital Affiliated to Changjiang University

Department of Oncology，Huanggang Central Hospital Affiliated to Changjiang University

⁰